THOUSAND OAKS, Calif., Dec. 8, 2010 /PRNewswire/ — Amgen
(Nasdaq:
AMGN) will participate in Deutsche Bank’s 2010 BioFEST on
Wednesday, Dec. 15, 2010, at the Four Seasons in Boston, beginning
at 10:00 a.m. Eastern Time. Roy Baynes, M.D., Ph.D., vice president
of Global Development and Arvind Sood, vice president, Investor
Relations will present at the conference. Live audio of the
presentation can be accessed from the Events Calendar on Amgen’s
website, www.amgen.com, under
Investors.
About AmgenAmgen discovers, develops, manufactures and
delivers innovative human therapeutics. A biotechnology
pioneer since 1980, Amgen was one of the first companies to realize
the new science’s promise by bringing safe and effective medicines
from lab, to manufacturing plant, to patient. Amgen
therapeutics have changed the practice of medicine, helping
millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses.
With a deep and broad pipeline of potential new medicines,
Amgen remains committed to advancing science to dramatically
improve people’s lives. To learn more about our pioneering
science and our vital medicines, visit www.amgen.com.CONTACT: Amgen,
Thousand OaksDavid Polk, 805-447-4613 (media)John Shutter,
805-447-1060 (investors)(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)
‘/>”/>
SOURCE